Clostridium Difficile News and Research

RSS

Clostridium difficile is a type of bacterium found in human and animal waste. Clostridium difficile is a common cause of diarrhea that occurs in hospitals. It can also cause diarrhea or other intestinal disorders in patients treated with antibiotics.

Rethinking the germ theory: A balanced take on microbes and disease outcomes

Review explores the complexities of infectious disease outcomes through a balanced perspective, emphasizing the interplay between pathogenic microbes and host conditions, challenging the traditional germ-disease theory by proposing a more integrated view that considers both pathogen virulence and host immunity's impact on disease manifestation.

10 Apr 2024

Revolutionizing critical care: the potential of gut microbiota therapeutics

The curative potential and limitations of gut microbiome-based therapeutics in critical illnesses.

13 Nov 2023

Doxycycline use may help protect against C. diff infection for some patients with pneumonia

A new study published today in the American Journal of Infection Control (AJIC) reveals that the use of doxycycline may help protect against Clostridioides difficile (C. diff) infection for some patients with pneumonia.

2 Nov 2023

Resistant potato starch usage found to be feasible and safe for hematopoietic stem cell transplantation patients

The use of resistant potato starch (RPS), to modify gut microbial metabolism.

24 Oct 2023

Researchers identify genes that may improve success of fecal microbe transplants

Fecal microbe transplants from healthy donors can treat patients with recurrent Clostridium difficile infections. However, after tens of thousands transplants, little was known about which donor strains provide long-term engraftment, and which engraft early after the transplant.

13 Oct 2023

Does your gut microbiome play a role in therapeutic outcomes?

The role of the gut microbiome and its metabolites in altering the therapeutic outcomes

12 Oct 2023

UKHSA unveils world-leading Vaccine Development and Evaluation Centre

The UK Health Security Agency (UKHSA) has today unveiled its world-leading Vaccine Development and Evaluation Centre (VDEC), which is building on its pandemic legacy and helping develop life-saving new vaccines for the UK and worldwide.

7 Aug 2023

Does COVID-19 increase the risk of future gastrointestinal disorders?

Scientists review existing literature to examine the association between acute COVID-19 and the incidence of gastrointestinal symptoms.

2 Aug 2023

What is the relationship between intestinal stem cells and the gut microbiota in regenerative medicine?

Researchers explored the relationship between intestinal stem cells (ISCs) and the gut microbiota and its role in maintaining intestinal health.

1 Aug 2023

Scientists use AI to identify new antibiotic that could fight drug-resistant infections

Using an artificial intelligence algorithm, researchers at MIT and McMaster University have identified a new antibiotic that can kill a type of bacteria that is responsible for many drug-resistant infections.

25 May 2023

Pawsitive test: Dogs sniff out COVID-19 with high accuracy, study shows

Researchers conduct a systematic review to determine the potential of using canine olfactory senses as a screening tool for COVID-19.

24 May 2023

Unlocking gut health: How indoor environment impacts the microbiota balance

Research paper highlights the importance of a diverse and balanced gut microbiota for human health, while emphasizing the need for further understanding of the impact of indoor microbiome and metabolites on gut microbiota.

21 May 2023

New antimicrobial coating material effectively kills bacteria and viruses

Researchers have used a common disinfectant and antiseptic to create a new antimicrobial coating material that effectively kills bacteria and viruses, including MRSA and Covid-19.

11 May 2023

Testing policy change could reduce the burden of C. diff infections

A new study published today in the American Journal of Infection Control suggests that allowing bedside nurses to independently order testing for C. difficile significantly decreased the amount of time to receive test results as compared to requiring physician approval.

11 May 2023

Fecal microbiota transplant: Effective solution for recurrent C. difficile infections

Researchers provide an overview of fecal microbiota transplantation in treating recurrent Clostridioides difficile infection.

27 Apr 2023

Discontinuing oral antibiotics after breast reconstruction does not lead to an increase in infections

For breast cancer patients undergoing breast reconstruction after mastectomy, avoiding postoperative oral antibiotics does not reduce the risk of infections, reports a study in the May issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons.

27 Apr 2023

Hospitals need to establish antimicrobial stewardship programs to prevent C. difficile infections

Five medical organizations say it is essential that hospitals establish antimicrobial stewardship programs to prevent Clostridioides difficile (C. difficile) infections.

12 Apr 2023

The burden of Clostridioides difficile infections in the United States

Researchers review existing data on Clostridioides difficile infections among United States residents.

13 Mar 2023

How the human gut microbiota is shaped by diet

A new study in the journal Best Practice & Research Clinical Gastroenterology aimed to summarize the impact of specific nutrients as well as diets on the gut microbiota as well as the future perspectives of using diet as a therapeutic microbiome modulator.

20 Feb 2023

Updated advice to prevent healthcare-associated infections focuses on hand hygiene

Five medical organizations are recommending updated best practices for hand hygiene to protect patients and staff in healthcare settings.

8 Feb 2023